| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |